Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Nurs 5225 Psychopharmacology APRN/MHN > PPT/ITP Model > Flashcards

PPT/ITP Model Flashcards

1
Q

Who can prescribe medication?

A

Advance Practice Nurses (NP, CNS, NMW, CRNA)
Physicians (MD, DO, ND) and Physician Assistants
Dentists
Veterinarians
Pharmacists and clinical psychologists, sometimes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who makes prescribing regulations

A 
Federal laws (ex. DEA)
State laws (ex. Marijuana)
Professional standards and professional licensing boards (ex. MN BON)
Local formularies (ex. insurance formularies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nurses have had an active role in prescribing both

A

formally and informally for over 50 years around the globe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Early reports of contraceptive prescribing in US and lower income countries in

A

1970s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prescriber role emerged in 1980s with the

A

expanded role of nurse practitioners in the US`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Increased nurse prescribing continued as

A

national and regional statutes were changed in Europe, Canada, and Australia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nurse prescribing spread in

A

Africa in early 2000s because of the increased use of inexpensive antiretroviral drugs for HIV or AIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do prescribers make prescribing decisions?

A

Prescribing Pyramid
STEPs
Prescribing Competency Framework
Ali Murshid & Mohaidin (2017) model for prescribing decisions
Psychopharmacotherapeutics (PPT) model for nurse prescribing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Steps of prescribing pyramid

A 
(Top)
Reflect 
Record Keeping 
Review 
Negotiate a contract 
Choice of Product
Which Strategy
Consider the patient 
(bottom)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

STEPs of Clinical Psychopharmacology

A

S= Safety; know the safety profile of the drug
T=Tolerability; evaluate short and long-term effects
E= Efficacy; evaluate clinical evidence
P= Practicality; consider cost, adherence, monitoring issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Updated RPS Prescribing Competency Framework

There are ten competencies split into two domains

A

The Consultation

  1. assess the patient
  2. consider the options
  3. reach a shared decision
  4. prescribe
  5. provide information
  6. monitor and review

Prescribing governance

  1. prescribe safety
  2. prescribe professionally
  3. improve prescribing practice
  4. prescribe as part of a team.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ali Murshid & Mohaidin Model for Prescribing Decisions

A

Patient characteristics: patient expectations and request for drug
Marketing efforts: drug information, drugs’ brand, marketing rep. effectiveness, promotion sales
Pharmacist factors: pharmacist-MD collaboration, pharmacist expert power
Contextual factors: trustworthiness, physician habits, cost/benefit ratio of a drug, drug characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PPT model was developed in

A

1996 to guide PMH APRNs with psychopharm decision-making when MN first legislated prescriptive authority for APRNs in 1995

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The PPT model incorporated

A

a holistic, nursing framework which is patient centered, rather than drug centered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The PPT model revised

A

over time to include integrative nursing concepts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

the PPT model has been used in

A

N5225 and other psychopharm courses in TN, WA, MI

17
Q

5 components that inform the PPT model treatment options

A

Patient context - what is wrong and what are the goals of treatment.

Scientific Evidence - Which treatment should be used, and how should it be used?

Legal and ethical standards

situational issues - What are the patient, provider, family and settings isuet to consider.

Which is best - non-pharm, medication, watchful waiting, or no fruther contact.

18
Q

After considering what informs the PPT model for decision making what comes next

A

Cost benefit considerations
Patient/Clinician shared decision making
Treatment Plan
Treatment outcomes.

19
Q

PPT to ITP Model

A

Evolving from a prescribing model to psychiatric APRN treatment planning framework

Can be used after diagnostic assessment/ problem identification

Incorporates all components of treatment planning, including medication prescribing

Now includes principles of Integrative Nursing

Uses a care mapping tool for patients and clinicians for shared decision-making and treatment planning

20
Q

ITP model what four items inform treatment options

A

Patient context
Scientific Evidence
Legal and Ethical Standards
Situational Issues

21
Q

ITP what comes after treatment options

A 
Risk Benefit 
Patient/Clinician Decision 
Treatment Plan 
Care Mapping Tool 
Treatment Outcomes
22
Q

The focus of the Patient Context is to

A

determine the patient variables that may influence our joint decision about treatment

23
Q

Patient Context Questions

A

What is the patient’s age/gender/culture or ethnicity?

What are the presenting physical and psychological symptoms?

How does the patient describe the problem and what is causing it?

What has the patient done so far to cope with the problem? Did it help or not?

What is the patient’s general health status? Are there any co-existing physical illnesses? What over the counter (OTC), prescribed, and herbal medications does the patient take and how often?

What is the patient’s mental and functional status? What is the patient’s primary language? What is the educational level and/ or how does the patient learn best?

What is the neurological assessment?
Is there a personal or family history of psychiatric illness, diagnosis, and/or treatment?

What is the social support or social network of the patient? Can the patient access treatment options?

What are the patient’s preferences for treatment? What is important to the patient’s quality of life?

24
Q

Ethical and Legal Questions

A

Are there regulations related to providing/prescribing this treatment?

Am I qualified to provide/prescribe this treatment?

What are the professional standards of practice the guide the provision of this treatment?

What ethical principles guide the treatment decisions?

Does the patient understand the risks and benefits of this treatment? Is there a question of competence?

Is there consent for treatment?

25
Q

Scientific Evidence Questions

A

What are the objectives of treatment?

What are the practice guidelines and/or scientific evidence for treating the
illness/symptoms?

What treatments are available?

What are the side effects and adverse effects of the treatment?

Is this a short term or a long term treatment option?

26
Q

Situational Issues considers

A

This component of the ITP model considers acceptability, availability, accessibility, and affordability of treatment options and resources to ensure successful treatment.

27
Q

Situational Questions

A

Is this treatment available to the patient?

Is the patient able to access this treatment?

Is this treatment acceptable to the patient?

Is the patient able to pay for this treatment? Is this treatment affordable short term and long-term? Are there outside resources that will help this patient afford this treatment?

Is there environmental/social support for the patient to engage in this treatment appropriately?

Does this treatment fit well with other interventions or activities patient is engaged in?
i.e. does it interact well with other treatments?

28
Q

Risk Benefit Questions

A

What are the specific target symptoms that can be treated?

What are the treatments that could be used to effectively treat these target symptoms?

What are the benefits of using this particular treatment?

Does the likely benefit of the treatment justify the risk of it?

How can I help my patient minimize the disadvantages to get the best effect from the treatment?

How will I monitor the side effects or adverse effects of the treatment?

29
Q

Patient/Clinician Questions

A

What are the options for treatment at this time?

What are the patient’s preferences for treatment?

What are the clinicians preferences for treatment?
Is the patient ready for treatment now?

What are the expected outcomes of the treatment?

30
Q

Watchful waiting: the best choice if:

A

close surveillance of the patient’s symptoms or illness is needed before making a decision

more information/records are needed

patient is undecided/ambivalent about treatment

includes self-care approaches for diet, exercise, nutrition, spirituality

could include traditional healing approaches

31
Q

Non-pharmacologic approaches:

A

natural products (aromatherapy, vitamins, melatonin)

movement ,energy and mind-body therapies; psychotherapy

light therapy, transmagnetic cranial stimulation, (TMS), biofeedback, EMDR

32
Q

Medication Management:

A

allopathic medicines

evidence-based homeopathic and Ayurvedic medicines

33
Q

No further contact:

A

consultation, end of treatment

34
Q

Treatment Options

A

Treatments to address illness and improve health

Management of treatment side effects

Patient/Family Education

Emergency/crisis management plans

Referrals

Follow-up appointment(s)

35
Q

ITP Care Mapping ToolStrengths-based –What are they already doing

A

Lifestyle and Environmental Health
Physical Health
Emotional and spiritual support

We fill in what people are already doing to be as strengths based as possible. Then we add in evidence based individualized suggestions that fit their needs and they they can do until next session without it adding more stress or overwhelm them. This may include specific referrals (E.g. for GP or MDR) or things we start (e.g. medications, vitamins, psychotherapy) or educate about or teach/train.
All of this then goes through other factors in the model (patient preference, risk benefit analysis, etc)

Over time both client and provider start thinking holistically and collaboratively about recovery, coping and interventions. Always adding things, taking away what does not work and keeping what does.

36
Q

ITP Care Mapping Tool - Physical Health

A 
Medications
On or off alcohol and drugs?
Recent labs and a NP/GP visit 
Vitamins and supplements
Diet
Sleep hygiene
Addressing long term and short term physical illness
Exercise
37
Q

ITP Care Mapping Tool - Lifestyle and Environmental

A 
Social activities and support
Nurturing activities
Management of stress
School work, training or courses for growth and/or nurture
Occupational rehabilitation
Financial stability
Environmental health
38
Q

ITP Care Mapping Tool - Emotional and Spiritual Health

A

Psychotherapy modalities
Meditative practices
Spirituality
Philosophy and outlook

Nurs 5225 Psychopharmacology APRN/MHN (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions